Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
A simple thyroid ratio could help spot frailty in older patients. A study of 112 hospitalized older adults in Italy found that a lower FT3-to-FT4 ratio — a marker of how well the body converts thyroid hormones — was independently linked to greater frailty. Since this ratio is already part of routine thyroid testing, it could become a convenient frailty screening tool in acute care settings.
Researchers in Italy have found that a lower ratio of free triiodothyronine (FT3) to free thyroxine (FT4) is independently associated with frailty in hospitalized older adults — even after accounting for age and cognitive function. The FT3/FT4 ratio reflects how efficiently the body converts thyroid hormones in peripheral tissues, and a lower ratio may be tied to the physiological decline seen in frailty.
The cross-sectional study analyzed 112 patients (median age 81) admitted to a geriatric unit. Frailty was assessed using a 46-item frailty index, and frail patients showed notably lower FT3 levels and FT3/FT4 ratios compared to non-frail peers. Importantly, standard markers like TSH and FT4 alone didn't differ between the groups — making the ratio a potentially more sensitive signal.
By the Numbers:
Why it matters: Since the FT3/FT4 ratio is already captured in routine thyroid panels, clinicians could use it as a low-cost, no-added-effort frailty screening tool — particularly valuable in acute care settings where early identification of frail patients can meaningfully shape treatment decisions.
